Oxybutynin chloride [USAN] | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Clinical Trials
- Clinical Trials
Drugs in Dev.
News
Blog
Market Place
Login

Oxybutynin Chloride [USAN]
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

Contact Supplier

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

Contact Supplier

pharmacompass-2-m-2026-04-20

Oxybutynin chloride [USAN]

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

25 API Suppliers, 12 USDMF, 10 CEP/COS, 2 JDMF, 3 EU WC, 1 KDMF, 10 NDC API, 8 Listed Suppliers

25 API Suppliers
12 USDMF
10 CEP/COS
2 JDMF
3 EU WC
1 KDMF
10 NDC API
8 Listed Suppliers

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

87 FDF Dossiers, 62 FDA Orange Book, 6 Europe, 9 Canada, 6 South Africa, 4 Listed Dossiers

87 FDF Dossiers
62 FDA Orange Book
6 Europe
9 Canada
6 South Africa
4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TRANSDERMAL - 10% (100MG/PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;TRANSDERMAL - 10% (100MG/PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Evonik, 2 Rochem International Inc, 20 SPI Pharma, 1 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 7 Kirsch Pharma, 7 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 30 BASF, 2 CD Formulation, 1 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 12 Gangwal Chemicals, 1 Gloria Interchem, 8 Ideal Cures, 5 Ingredion Pharma Solutions, 1 JJ Chemicals, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Pharmachem, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 2 The Dow Chemical Company, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

71 Fillers, Diluents & Binders, 61 Coating Systems & Additives, 40 Direct Compression, 36 Controlled & Modified Release, 33 Granulation, 31 Solubilizers, 29 Parenteral, 29 Disintegrants & Superdisintegrants, 29 Taste Masking, 29 Thickeners and Stabilizers, 26 Film Formers & Plasticizers, 22 Lubricants & Glidants, 21 Topical, 19 Chewable & Orodispersible Aids, 14 Co-Processed Excipients, 12 API Stability Enhancers, 9 Emulsifying Agents, 6 Surfactant & Foaming Agents, 5 Empty Capsules, 5 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

71 Fillers, Diluents & Binders
61 Coating Systems & Additives
40 Direct Compression
36 Controlled & Modified Release
33 Granulation
31 Solubilizers
29 Parenteral
29 Disintegrants & Superdisintegrants
29 Taste Masking
29 Thickeners and Stabilizers
26 Film Formers & Plasticizers
22 Lubricants & Glidants
21 Topical
19 Chewable & Orodispersible Aids
14 Co-Processed Excipients
12 API Stability Enhancers
9 Emulsifying Agents
6 Surfactant & Foaming Agents
5 Empty Capsules
5 Rheology Modifiers
4 Vegetarian Capsules
2 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

17 News #PharmaBuzz

17 News #PharmaBuzz

GLOBAL SALES INFORMATION

34 US Medicaid Prescriptions, 12 Regulatory FDF Prices

34 US Medicaid Prescriptions
12 Regulatory FDF Prices

MARKET PLACE

11 APIs

11 APIs

PATENTS & EXCLUSIVITIES

3 US Patents, 6 Health Canada Patents

3 US Patents
6 Health Canada Patents

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

19 All

01 3ABBVIE

02 16IRONSHORE PHARMS

filter Patent Number Reset all filters

19 All

01 18916588

02 18920392

03 18927010

04 19023389

05 19028868

06 19034902

07 19259388

08 19283214

09 19498447

10 19603809

11 110182995

12 110292937

13 110449173

14 110617651

15 110881618

16 110905652

17 111241391

18 111241392

19 111911518

API Patent Reset all filters

19 All

01 19Blank

filter FDF Patent Reset all filters

19 All

01 8Y

02 11Blank

filter Expiration Date Reset all filters

19 All

01 22029-11-06

02 12031-03-26

03 162032-03-23

Oxybutynin Hydrochloride

Product Main Page

01

ABBVIE

PEGS Boston Summit

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-03-26

OXYBUTYNIN CHLORIDE

US Patent Number : 8920392

Drug Substance Claim :

Drug Product Claim :

Application Number : 22204

Patent Use Code : U-1644

Delist Requested :

Patent Use Description : TREATMENT OF OVERACTIV...

Patent Expiration Date : 2031-03-26

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ABBVIE

PEGS Boston Summit

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-11-06

OXYBUTYNIN CHLORIDE

US Patent Number : 10449173

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22204

Patent Use Code : U-2637

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-11-06

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ABBVIE

PEGS Boston Summit

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-11-06

OXYBUTYNIN CHLORIDE

US Patent Number : 9259388

Drug Substance Claim :

Drug Product Claim :

Application Number : 22204

Patent Use Code : U-1644

Delist Requested :

Patent Use Description : TREATMENT OF OVERACTIV...

Patent Expiration Date : 2029-11-06

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

IRONSHORE PHARMS

METHYLPHENIDATE HYDROCHLORIDE

PEGS Boston Summit

Not Confirmed

IRONSHORE PHARMS

Country

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-03-23

METHYLPHENIDATE HYDROCHLORIDE

US Patent Number : 8916588

Drug Substance Claim :

Drug Product Claim :

Application Number : 209311

Patent Use Code : U-2357

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-03-23

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

IRONSHORE PHARMS

METHYLPHENIDATE HYDROCHLORIDE

PEGS Boston Summit

Not Confirmed

IRONSHORE PHARMS

Country

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-03-23

METHYLPHENIDATE HYDROCHLORIDE

US Patent Number : 9603809

Drug Substance Claim :

Drug Product Claim :

Application Number : 209311

Patent Use Code : U-2357

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-03-23

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

IRONSHORE PHARMS

METHYLPHENIDATE HYDROCHLORIDE

PEGS Boston Summit

Not Confirmed

IRONSHORE PHARMS

Country

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-03-23

METHYLPHENIDATE HYDROCHLORIDE

US Patent Number : 9028868

Drug Substance Claim :

Drug Product Claim :

Application Number : 209311

Patent Use Code : U-2357

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-03-23

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

IRONSHORE PHARMS

METHYLPHENIDATE HYDROCHLORIDE

PEGS Boston Summit

Not Confirmed

IRONSHORE PHARMS

Country

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-03-23

METHYLPHENIDATE HYDROCHLORIDE

US Patent Number : 9034902

Drug Substance Claim :

Drug Product Claim :

Application Number : 209311

Patent Use Code : U-2357

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-03-23

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

IRONSHORE PHARMS

METHYLPHENIDATE HYDROCHLORIDE

PEGS Boston Summit

Not Confirmed

IRONSHORE PHARMS

Country

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-03-23

METHYLPHENIDATE HYDROCHLORIDE

US Patent Number : 10292937

Drug Substance Claim :

Drug Product Claim :

Application Number : 209311

Patent Use Code : U-2357

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-03-23

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

IRONSHORE PHARMS

METHYLPHENIDATE HYDROCHLORIDE

PEGS Boston Summit

Not Confirmed

IRONSHORE PHARMS

Country

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-03-23

METHYLPHENIDATE HYDROCHLORIDE

US Patent Number : 10617651

Drug Substance Claim :

Drug Product Claim :

Application Number : 209311

Patent Use Code : U-2357

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-03-23

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

IRONSHORE PHARMS

METHYLPHENIDATE HYDROCHLORIDE

PEGS Boston Summit

Not Confirmed

IRONSHORE PHARMS

Country

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-03-23

METHYLPHENIDATE HYDROCHLORIDE

US Patent Number : 10881618

Drug Substance Claim :

Drug Product Claim :

Application Number : 209311

Patent Use Code : U-2357

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-03-23

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.